How many employees does Guardant Health, Inc. have?

Guardant Health, Inc. reported 2,490 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 19, 2026. That is up 24.6% from a year earlier.

What is Guardant Health, Inc.'s revenue per employee?

Guardant Health, Inc. brought in $982M of revenue in fiscal Dec 2025, which is $394K per employee. That ranks 7 of 18 companies we track in Medical - Diagnostics & Research, where the median is $380K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Guardant Health, Inc. employees and revenue per employee

GH · Medical - Diagnostics & Research · $23.9B market cap

Guardant Health, Inc. had 2,490 employees at the end of fiscal Dec 2025, up 24.6% from a year earlier. Revenue for the year was $982M, up 32.9% from a year earlier, or $394K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

2,490

+24.6% YoY

Revenue

$982M

+32.9% YoY

Revenue / employee

$394K

Peer median $380K

Rank in industry

7 of 18

Medical - Diagnostics & Research

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2018

Hover a year for the numbers.

GH employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	2,490	$982M	$394K	+24.6%	+32.9%
Dec 2024	1,999	$739M	$370K	+13.1%	+31.0%
Dec 2023	1,768	$564M	$319K	-1.4%	+25.5%
Dec 2022	1,793	$450M	$251K	+30.6%	+20.3%
Dec 2021	1,373	$374M	$272K	+58.9%	+30.3%
Dec 2020	864	$287M	$332K	+38.9%	+33.8%
Dec 2019	622	$214M	$345K	+37.0%	+136.5%
Dec 2018	454	$90.6M	$200K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Guardant Health, Inc. against similar companies

The closest industry peers by revenue, from Medical - Diagnostics & Research.

Company	Employees	Revenue	Revenue / employee	Shape
VCYT Veracyte, Inc.	755	$517M	$685K	Leaner
CDNA CareDx, Inc	761	$380M	$499K	Hiring ahead
MEDP Medpace Holdings, Inc.	6,200	$2.53B	$408K	Efficient growth
WAT Waters Corporation	7,900	$3.17B	$401K	Efficient growth
GH Guardant Health, Inc.	2,490	$982M	$394K	Efficient growth
NTRA Natera, Inc.	6,135	$2.31B	$376K	Hiring ahead
NEOG Neogen Corporation	2,636	$870M	$330K	Contracting
RVTY Revvity, Inc.	11,000	$2.86B	$260K	Leaner
CRL Charles River Laboratories International, Inc.	19,700	$4.02B	$204K	Contracting

Every Healthcare company

Questions about Guardant Health, Inc.

How many employees does Guardant Health, Inc. have?: Guardant Health, Inc. reported 2,490 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 19, 2026. That is up 24.6% from a year earlier.
What is Guardant Health, Inc.'s revenue per employee?: Guardant Health, Inc. brought in $982M of revenue in fiscal Dec 2025, which is $394K per employee. That ranks 7 of 18 companies we track in Medical - Diagnostics & Research, where the median is $380K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare GH with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Guardant Health, Inc.'s annual reports (Form 10-K), latest filed February 19, 2026. This is data, not a recommendation to buy or sell GH.